Literature DB >> 3601807

Activated Ki-ras oncogene in human prostatic adenocarcinoma.

D M Peehl, N Wehner, T A Stamey.   

Abstract

The role of cellular oncogenes in the development of human prostate cancer has not been extensively studied. A search for activated oncogenes was undertaken by testing DNA isolated from prostatic adenocarcinoma tissues for transforming activity in a 3T3 transfection assay. A transforming sequence homologous to Ki-ras was detected in one of the samples. DNA from the other cancers was negative in the transformation assay, suggesting that the activation of oncogenes, at least those detectable by the 3T3 transfection assay, is not a frequent event in prostate cancer. Amplification of genomic oncogene sequences in prostatic tissues was also examined, but amplification of Ki-ras, Ha-ras, c-myc, N-myc, c-sis, or c-fos was not detectable in any of the samples.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3601807     DOI: 10.1002/pros.2990100402

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  10 in total

Review 1.  Morphologic and regulatory aspects of prostatic function.

Authors:  G Aumüller
Journal:  Anat Embryol (Berl)       Date:  1989

Review 2.  Oncogenes and urological malignancies: implications for the future.

Authors:  J A Schalken; A M van den Ouweland; F M Debruijne; H F Karthaus; W J Van de Ven
Journal:  Urol Res       Date:  1988

3.  Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.

Authors:  R Bookstein; P Rio; S A Madreperla; F Hong; C Allred; W E Grizzle; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene.

Authors:  A Tehranian; D W Morris; B H Min; D J Bird; R D Cardiff; P A Barry
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 5.  Molecular biology of prostate cancer.

Authors:  X B Shi; P H Gumerlock; R W deVere White
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

6.  Effects of sex steroids on cell growth and C-myc oncogene expression in LN-CaP and DU-145 prostatic carcinoma cell lines.

Authors:  F K Asadi; R Sharifi
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

7.  Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma.

Authors:  N Konishi; Y Hiasa; H Matsuda; M Tao; T Tsuzuki; I Hayashi; Y Kitahori; T Shiraishi; R Yatani; J Shimazaki
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

8.  Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer.

Authors:  V W Merz; A M Arnold; U E Studer
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  Mouse models of prostate cancer.

Authors:  Kenneth C Valkenburg; Bart O Williams
Journal:  Prostate Cancer       Date:  2011-02-23

10.  p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries.

Authors:  M Watanabe; T Ushijima; H Kakiuchi; T Shiraishi; R Yatani; J Shimazaki; T Kotake; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1994-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.